hydrogen sulfide-releasing derivative of ketoprofen (ATB-352) - Antibe
https://www.businesswire.com/news/home/20210111005389/en/Antibe-Therapeutics-Provides-2021-Corporate-Update
 
Jan 11, 2021
 
Prev Next